345 related articles for article (PubMed ID: 23552422)
1. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures.
Chan RW; Chan MC; Agnihothram S; Chan LL; Kuok DI; Fong JH; Guan Y; Poon LL; Baric RS; Nicholls JM; Peiris JS
J Virol; 2013 Jun; 87(12):6604-14. PubMed ID: 23552422
[TBL] [Abstract][Full Text] [Related]
2. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus.
Zielecki F; Weber M; Eickmann M; Spiegelberg L; Zaki AM; Matrosovich M; Becker S; Weber F
J Virol; 2013 May; 87(9):5300-4. PubMed ID: 23449793
[TBL] [Abstract][Full Text] [Related]
3. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential.
Kindler E; Jónsdóttir HR; Muth D; Hamming OJ; Hartmann R; Rodriguez R; Geffers R; Fouchier RA; Drosten C; Müller MA; Dijkman R; Thiel V
mBio; 2013 Feb; 4(1):e00611-12. PubMed ID: 23422412
[TBL] [Abstract][Full Text] [Related]
4. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus.
Josset L; Menachery VD; Gralinski LE; Agnihothram S; Sova P; Carter VS; Yount BL; Graham RL; Baric RS; Katze MG
mBio; 2013 Apr; 4(3):e00165-13. PubMed ID: 23631916
[TBL] [Abstract][Full Text] [Related]
5. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
[TBL] [Abstract][Full Text] [Related]
6. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
7. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.
Müller MA; Raj VS; Muth D; Meyer B; Kallies S; Smits SL; Wollny R; Bestebroer TM; Specht S; Suliman T; Zimmermann K; Binger T; Eckerle I; Tschapka M; Zaki AM; Osterhaus AD; Fouchier RA; Haagmans BL; Drosten C
mBio; 2012 Dec; 3(6):. PubMed ID: 23232719
[TBL] [Abstract][Full Text] [Related]
8. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
[TBL] [Abstract][Full Text] [Related]
9. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation.
Chan JF; Chan KH; Choi GK; To KK; Tse H; Cai JP; Yeung ML; Cheng VC; Chen H; Che XY; Lau SK; Woo PC; Yuen KY
J Infect Dis; 2013 Jun; 207(11):1743-52. PubMed ID: 23532101
[TBL] [Abstract][Full Text] [Related]
10. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
Lau SKP; Lau CCY; Chan KH; Li CPY; Chen H; Jin DY; Chan JFW; Woo PCY; Yuen KY
J Gen Virol; 2013 Dec; 94(Pt 12):2679-2690. PubMed ID: 24077366
[TBL] [Abstract][Full Text] [Related]
11. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.
Loo SL; Wark PAB; Esneau C; Nichol KS; Hsu AC; Bartlett NW
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L926-L931. PubMed ID: 32903043
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
13. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.
Gierer S; Bertram S; Kaup F; Wrensch F; Heurich A; Krämer-Kühl A; Welsch K; Winkler M; Meyer B; Drosten C; Dittmer U; von Hahn T; Simmons G; Hofmann H; Pöhlmann S
J Virol; 2013 May; 87(10):5502-11. PubMed ID: 23468491
[TBL] [Abstract][Full Text] [Related]
14. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.
Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S
mBio; 2016 Dec; 7(6):. PubMed ID: 27965448
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism.
Dijkman R; Jebbink MF; Koekkoek SM; Deijs M; Jónsdóttir HR; Molenkamp R; Ieven M; Goossens H; Thiel V; van der Hoek L
J Virol; 2013 Jun; 87(11):6081-90. PubMed ID: 23427150
[TBL] [Abstract][Full Text] [Related]
16. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
[TBL] [Abstract][Full Text] [Related]
17. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
[TBL] [Abstract][Full Text] [Related]
19. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
20. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.
Carbajo-Lozoya J; Müller MA; Kallies S; Thiel V; Drosten C; von Brunn A
Virus Res; 2012 Apr; 165(1):112-7. PubMed ID: 22349148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
